Keywords: glaxo, wellcome, jan-oct, trading, results, see, sales
Glaxo Wellcome Jan-Oct trading results see sales up 6%
Article | 17 November 1999
Reporting for the 10 months to October 31, Glaxo Wellcome said saleswere L6.88 billion ($11.16 billion), up 6% over the like, year-earlier period, and 5% ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Is failure to adopt business process management putting the pharma industry at risk?
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- New Zealand declines Alexion's funding application for Solaris
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
